Stevanato Group SpA (STU:87N) Growth Rank: 8 (As of Sep. 09, 2026) — 11% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:87N Stevanato Group SpA STU:87N
88 GF Score
Price €17.30
GF Value €22.17
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Stevanato Group SpA Growth Rank?

Stevanato Group SpA STU:87N 88 Growth Rank is 8 as of Sep. 09, 2026, which is 11% below its 10-year median of 9.00. GuruFocus rates STU:87N with a GF Score™ of 88/100 and a GF Value™ of €22.17 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Stevanato Group SpA has the Growth Rank of 8.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Stevanato Group SpA Growth Rank Related Terms

STU:87N vs MMED, TFX, MMSI: Growth Rank Comparison

For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stevanato Group SpA Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Growth Rank distribution charts can be found below:

* The bar in red indicates where Stevanato Group SpA's Growth Rank falls into.


STU:87N
88GF Score
Stevanato Group SpA STU:87N
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 8 mean?
Stevanato Group SpA (STU:87N) has a Growth Rank of 8 as of Sep. 09, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Stevanato Group SpA and its competitors. This is 11% below median its historical median of 9.00. Over the past decade, Stevanato Group SpA's Growth Rank has ranged from 8.00 to 9.00.
Is Stevanato Group SpA's Growth Rank too high?
Stevanato Group SpA's current Growth Rank of 8 is 11% below median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 8.00 to a high of 9.00. Overall, Stevanato Group SpA has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Growth Rank compare to MMED and TFX?
Stevanato Group SpA's Growth Rank of 8 can be compared against companies in the Medical Devices & Instruments industry. Historically, Stevanato Group SpA's own Growth Rank has ranged from 8.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Stevanato Group SpA and its competitors. Stevanato Group SpA's current Growth Rank is 8, which is 11% below median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (STU:87N) is currently considered Modestly Undervalued. The stock's GF Value™ is €22.17, compared to a current price of €17.30 — trading 22% below its estimated fair value. The current Growth Rank is 8, which is 11% below median its 10-year median of 9.00. Stevanato Group SpA's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Stevanato Group SpA (STU:87N), the current Growth Rank is 8 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stevanato Group SpA (STU:87N) Overvalued in 2026?

Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued. The current stock price of €17.30 is trading 22% below its estimated GF Value™ of €22.17. GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.

Key valuation signals for STU:87N:

  • Growth Rank: 8 (11% below median its 10-year median of 9.00)
  • GF Value™: €22.17 vs. price of €17.30 (22% below fair value)
  • GF Score™: 88/100 with 6 warning signs

No single metric tells the full story. See the STU:87N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stevanato Group SpA Business Description

Other Exchanges STVN:USA
Address Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
88GF Score

Get the complete analysis for STU:87N

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.30
Price
€22.17
GF Value